Innate pharma to participate in the Leerink Partners Global Healthcare Conference

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in a fireside chat and one-on-one meetings at the following conference:

Leerink Partners Global Healthcare Conference 2026

  • Dates: March 8–11, 2026
  • Location: Miami, Florida, United States

Fireside chat:

  • Date: March 9, 2026
  • Time: 3:40 PM ET / 8:40 PM CET
  • To enter the live webcast, please click here

The link to access the live webcast of the presentation will be available on the Events page of the Investors section of Innate Pharma’s website. A replay of the presentation will be available following the event.